搜尋
Merus NV
MRUS添加自選
90.000USD
0.0000.00%
收盤 06/30, 16:00（美東）報價延遲15分鐘
6.83B總市值
虧損本益比TTM
關於 Merus NV 公司
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Merus NV簡介
公司代碼MRUS
公司名稱Merus NV
上市日期May 19, 2016
CEOLundberg (Sven Ante)
員工數量260
證券類型Ordinary Share
年結日May 19
公司地址Yalelaan 62
城市UTRECHT
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Netherlands
郵編3584 CM
電話310302538800
網址https://merus.nl/
公司代碼MRUS
上市日期May 19, 2016
CEOLundberg (Sven Ante)
Merus NV公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
168.44K
-17.99%
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Paolo Pucci
Mr. Paolo Pucci
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Victor Sandor, M.D.
Dr. Victor Sandor, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Sherri Spear
Ms. Sherri Spear
Investor Relations and Corporate Communications
Investor Relations and Corporate Communications
--
--
Dr. Maxine Gowen, Ph.D.
Dr. Maxine Gowen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Sven Ante (Bill) Lundberg, M.D.
Dr. Sven Ante (Bill) Lundberg, M.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
168.44K
-17.99%
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter B. Silverman, J.D.
Mr. Peter B. Silverman, J.D.
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
--
--
Dr. Anand Mehra, M.D.
Dr. Anand Mehra, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Leonard (Len) Kanavy
Mr. Leonard (Len) Kanavy
Non-Executive Independent Director
Non-Executive Independent Director
--
--
常見問題
Merus NV的前五大股東是誰？
Merus NV的前五大股東如下：Dr. Sven Ante (Bill) Lundberg, M.D.
有多少機構持有Merus NV(MRUS)的股份？
截至2025Q4，共有498家機構持有Merus NV的股份，合計持有的股份價值約為69.89M，占公司總股份的92.15% 。與2025Q3相比，機構持股有所增加，增幅為-15184959.00。
